Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Lorcaserin therapy for severe epilepsy of childhood onset: A case series.

Tolete P, Knupp K, Karlovich M, DeCarlo E, Bluvstein J, Conway E, Friedman D, Dugan P, Devinsky O.

Neurology. 2018 Oct 30;91(18):837-839. doi: 10.1212/WNL.0000000000006432. Epub 2018 Sep 26. No abstract available.

2.

The impact of hypsarrhythmia on infantile spasms treatment response: Observational cohort study from the National Infantile Spasms Consortium.

Demarest ST, Shellhaas RA, Gaillard WD, Keator C, Nickels KC, Hussain SA, Loddenkemper T, Patel AD, Saneto RP, Wirrell E, Sánchez Fernández I, Chu CJ, Grinspan Z, Wusthoff CJ, Joshi S, Mohamed IS, Stafstrom CE, Stack CV, Yozawitz E, Bluvstein JS, Singh RK, Knupp KG; Pediatric Epilepsy Research Consortium.

Epilepsia. 2017 Dec;58(12):2098-2103. doi: 10.1111/epi.13937. Epub 2017 Nov 3.

3.

Cannabidiol as a Potential Treatment for Febrile Infection-Related Epilepsy Syndrome (FIRES) in the Acute and Chronic Phases.

Gofshteyn JS, Wilfong A, Devinsky O, Bluvstein J, Charuta J, Ciliberto MA, Laux L, Marsh ED.

J Child Neurol. 2017 Jan;32(1):35-40. doi: 10.1177/0883073816669450. Epub 2016 Sep 29.

PMID:
27655472
4.

Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial.

Devinsky O, Marsh E, Friedman D, Thiele E, Laux L, Sullivan J, Miller I, Flamini R, Wilfong A, Filloux F, Wong M, Tilton N, Bruno P, Bluvstein J, Hedlund J, Kamens R, Maclean J, Nangia S, Singhal NS, Wilson CA, Patel A, Cilio MR.

Lancet Neurol. 2016 Mar;15(3):270-8. doi: 10.1016/S1474-4422(15)00379-8. Epub 2015 Dec 24. Erratum in: Lancet Neurol. 2016 Apr;15(4):352.

PMID:
26724101
5.

Treatment Resistant Epilepsy in Autism Spectrum Disorder: Increased Risk for Females.

Blackmon K, Bluvstein J, MacAllister WS, Avallone J, Misajon J, Hedlund J, Goldberg R, Bojko A, Mitra N, Giridharan R, Sultan R, Keller S, Devinsky O.

Autism Res. 2016 Feb;9(2):311-20. doi: 10.1002/aur.1514. Epub 2015 Jun 26.

PMID:
26112160
6.

Auras in generalized epilepsy.

Dugan P, Carlson C, Bluvstein J, Chong DJ, Friedman D, Kirsch HE; EPGP Investigators.

Neurology. 2014 Oct 14;83(16):1444-9. doi: 10.1212/WNL.0000000000000877. Epub 2014 Sep 17.

7.

The epilepsy phenome/genome project.

EPGP Collaborative, Abou-Khalil B, Alldredge B, Bautista J, Berkovic S, Bluvstein J, Boro A, Cascino G, Consalvo D, Cristofaro S, Crumrine P, Devinsky O, Dlugos D, Epstein M, Fahlstrom R, Fiol M, Fountain N, Fox K, French J, Freyer Karn C, Friedman D, Geller E, Glauser T, Glynn S, Haas K, Haut S, Hayward J, Helmers S, Joshi S, Kanner A, Kirsch H, Knowlton R, Kossoff E, Kuperman R, Kuzniecky R, Lowenstein D, McGuire S, Motika P, Nesbitt G, Novotny E, Ottman R, Paolicchi J, Parent J, Park K, Poduri A, Risch N, Sadleir L, Scheffer I, Shellhaas R, Sherr E, Shih JJ, Shinnar S, Singh R, Sirven J, Smith M, Sullivan J, Thio LL, Venkat A, Vining E, von Allmen G, Weisenberg J, Widdess-Walsh P, Winawer M.

Clin Trials. 2013 Aug;10(4):568-86. doi: 10.1177/1740774513484392. Epub 2013 Jul 1.

8.

Medically refractory epilepsy in autism.

Sansa G, Carlson C, Doyle W, Weiner HL, Bluvstein J, Barr W, Devinsky O.

Epilepsia. 2011 Jun;52(6):1071-5. doi: 10.1111/j.1528-1167.2011.03069.x. Epub 2011 Apr 19.

Supplemental Content

Loading ...
Support Center